These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19741236)

  • 1. Autologous stem-cell transplantation for multiple myeloma.
    Louw VJ; Louw H; Webb MJ
    N Engl J Med; 2009 Sep; 361(11):1118-9; author reply 1119. PubMed ID: 19741236
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of autologous peripheral blood stem cell transplantation for multiple myeloma: a multi-institutional survey].
    Inaba W; Shimazaki C
    Rinsho Ketsueki; 2002 May; 43(5):337-40. PubMed ID: 12096481
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple myeloma--new therapeutic perspectives].
    Skotnicki AB; Wolska-Smoleń T; Jurczyszyn A
    Przegl Lek; 1999; 56 Suppl 1():67-72. PubMed ID: 10494186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation in multiple myeloma.
    Pant S; Copelan EA
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation.
    Chang H; Qi XY; Samiee S; Yi QL; Chen C; Trudel S; Mikhael J; Reece D; Stewart AK
    Bone Marrow Transplant; 2005 Nov; 36(9):793-6. PubMed ID: 16113669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
    Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Grafone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L
    J Clin Oncol; 2006 Jan; 24(3):e4-5. PubMed ID: 16421414
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic factors and staging in multiple myeloma.
    Fonseca R; San Miguel J
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1115-40, ix. PubMed ID: 17996591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hematopoietic stem cell transplantation for multiple myeloma].
    Miwa A
    Rinsho Ketsueki; 1997 Apr; 38(4):296-301. PubMed ID: 9146055
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous stem cell transplantation in multiple myeloma: none, one, or two?
    Harousseau JL
    Curr Hematol Rep; 2003 May; 2(3):171-2. PubMed ID: 12901337
    [No Abstract]   [Full Text] [Related]  

  • 10. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous transplantation in multiple myeloma.
    Bladé J
    Haematologica; 2006 Sep; 91(9):1157. PubMed ID: 16956811
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hematopoietic stem cell transplantation in multiple myeloma].
    Okamoto S
    Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1127-31. PubMed ID: 7561371
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autologous stem cell transplantation for multiple myeloma].
    Shimazaki C
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():642-5. PubMed ID: 17474472
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic factors in multiple myeloma: practicability for clinical practice and future perspectives.
    Haferlach T; Löffler H
    Leukemia; 1997 Dec; 11 Suppl 5():S5-9. PubMed ID: 9436931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcal meningitis following autologous stem cell transplantation in a patient with multiple myeloma.
    Mendpara SD; Ustun C; Kallab AM; Mazzella FM; Bilodeau PA; Jillella AP
    Bone Marrow Transplant; 2002 Aug; 30(4):259-60. PubMed ID: 12203144
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.
    Khaled Y; Mellacheruvu S; Reddy P; Peres E; Mineishi S
    Bone Marrow Transplant; 2009 Sep; 44(5):325-6. PubMed ID: 19204708
    [No Abstract]   [Full Text] [Related]  

  • 17. Allografting or autografting for myeloma.
    Moreau P; Harousseau JL; Attal M
    N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600892
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status and future directions in the treatment of multiple myeloma.
    Hou J; Wang M
    Chin Med J (Engl); 2007 Oct; 120(19):1651-4. PubMed ID: 17935663
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of multiple myeloma: a new molecular target therapy].
    Ozaki S; Kosaka M
    Rinsho Ketsueki; 2000 May; 41(5):421-5. PubMed ID: 10879104
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors in multiple myeloma.
    Tricot G
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):167-8. PubMed ID: 16166987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.